Advancing cellular research

Scientific research is at the heart of Queens Medical Center. Our research focuses on the use of induced pluripotent stem cells (iPSC) for regenerative medicine.

iPSCs are a type of pluripotent stem cell that can be generated directly from a somatic cell. Pioneered by Shinya Yamanaka’s lab in Kyoto, Japan, iPSC technology holds promise in the field of regenerative medicine as these stem cells represent a single source of cells that could be used to replace those lost to damage or disease.

Since iPSCs can be derived directly from adult tissues, they not only bypass the need for embryos, but can be made in a patient-matched manner, which means that each individual could have their own pluripotent stem cell line. These unlimited supplies of autologous cells could be used to generate transplants without the risk of immune rejection.